WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build International flag

WHO Antenatal Care Guideline Implementation Guide, published by World Health Organization (WHO). This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-anc/ and changes regularly. See the Directory of published versions

PlanDefinition: ANC.DT.38 Deworming and malaria prophylaxis

Official URL: http://smart.who.int/anc/PlanDefinition/ANCDT38 Version: 0.3.0
Active as of 2025-06-24 Computable Name: ANCDT38
Other Identifiers: ANC.DT.38 (use: official, )

Usage:Workflow Task: Counselling, in-facility management & treatment

IF the woman is currently in a malaria-endemic setting, or in an area where there is greater than 20% prevalence of infection with any soil-transmitted helminths, THEN she should receive preventative treatment accordingly

Id: ANCDT38
Url: ANC.DT.38 Deworming and malaria prophylaxis
Version: 0.3.0
Official

ANC.DT.38

Title: ANC.DT.38 Deworming and malaria prophylaxis
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2025-06-24 13:58:48-0600
Publisher: World Health Organization (WHO)
Description:

IF the woman is currently in a malaria-endemic setting, or in an area where there is greater than 20% prevalence of infection with any soil-transmitted helminths, THEN she should receive preventative treatment accordingly
Use Context:
code value
task
Jurisdiction: 001
Libraries:
ANC.DT.38 Deworming and malaria prophylaxis
Actions:
ANC.DT.38 Deworming and malaria prophylaxis:
When: Named Event: ANC.B10. Counselling, in-facility management and treatment
Then:
Sleeping under an insecticide-treated bednet and the importance of seeking care and getting treatment as soon as she has any symptoms
If: Applicability: Malaria-endemic setting = TRUE (Should Provide malaria prophylaxis)
IF the woman is currently taking co-trimoxazole, even in a malaria-endemic setting, she should not receive any dose of IPTp-SP. Women who are taking co-trimoxazole SHOULD NOT receive IPTp-SP. Taking both co-trimoxazole and IPTp-SP together can enhance side-effects, especially haematological side-effects such as anaemia.
If: Applicability: (Malaria-endemic setting = TRUE) AND (Current medications" = "Co-trimoxazole") (Should Do not give IPTp-SP, because woman is taking co-trimoxazole)
In areas with a population prevalence of infection with any soil-transmitted helminths of 20% or higher OR a population anaemia prevalence 40% or higher, preventive anthelminthic treatment is recommended for pregnant women after the first trimester as part of worm infection reduction programmes
If: Applicability: ("Population prevalence of soil-transmitted helminth infection" ≥ 20% ) OR ("Population prevalence of anaemia" ≥ 40%) (Should Conduct deworming)